Hspa1A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Full Name: Heat Shock Protein Family A (Hsp70) Member 1A
Chromosomal Location: 6p21.33
NCBI Gene ID: 3312
OMIM: 140100
Ensembl ID: ENSG00000213401
UniProt ID: P0DMV8
Associated Diseases: Alzheimer's Disease, Parkinson's Disease, ALS, Huntington's Disease
HSPA1A (Heat Shock Protein Family A (Hsp70) Member 1A) encodes a 70-kDa heat shock protein, also known as Hsp70-1 or Hsp70. This protein is a member of the Hsp70 family of molecular chaperones that play critical roles in protein folding, refolding, and degradation.
HSPA1A is a highly conserved molecular chaperone that participates in various cellular processes:
- Protein folding assistance: Hsp70 binds to nascent polypeptide chains and facilitates correct folding
- Protein refolding: Following cellular stress (heat, oxidative damage), Hsp70 helps refold denatured proteins
- Protein degradation: Cooperates with the proteasome and autophagy systems to clear misfolded proteins
- Anti-aggregation: Prevents aggregation of misfolded proteins that could form toxic oligomers
The HSPA1A gene is transcriptionally activated by heat shock factor 1 (HSF1) in response to cellular stress. Under normal conditions, Hsp70 levels are relatively low, but they increase dramatically following heat shock or other proteotoxic stresses.
In Alzheimer's disease, HSPA1A has been studied extensively for its role in modulating amyloid-beta (Aβ) pathology:
- Hsp70 can bind to Aβ peptides and reduce their aggregation into toxic oligomers and plaques
- Hsp70 promotes the degradation of Aβ through the ubiquitin-proteasome system
- Genetic variants in HSPA1A have been associated with altered Alzheimer's disease risk
- Hsp70 levels are elevated in Alzheimer's disease brains, possibly as a protective response
In Parkinson's disease, Hsp70 plays several protective roles:
- Hsp70 can prevent α-synuclein aggregation and toxicity
- Hsp70 assists in the refolding of damaged proteins in dopaminergic neurons
- Hsp70 promotes mitophagy to remove damaged mitochondria
- Animal models show that Hsp70 overexpression protects against MPTP-induced dopaminergic neuron loss
Hsp70 is implicated in ALS through multiple mechanisms:
- Mutant SOD1 and TDP-43 proteins can be refolded by Hsp70
- Hsp70 reduces aggregation of FUS protein
- Hsp70 cooperates with other chaperones (Hsp40, Hsp110) in protein homeostasis
- Dysregulation of Hsp70 is observed in ALS patient motor neurons
In Huntington's disease:
- Hsp70 can reduce mutant huntingtin protein aggregation
- Hsp70 modulates the toxicity of polyglutamine-expanded huntingtin
- Hsp70 collaborates with Hsp40 to enhance huntingtin clearance
- Therapeutic strategies involving Hsp70 activators are being explored
HSPA1A is expressed in most tissues, including the brain:
- High expression: Brain, heart, skeletal muscle, testis
- Cellular localization: Cytoplasm, nucleus, and can translocate to various organelles under stress
- Regional expression in brain: Widely expressed across cortical regions, hippocampus, cerebellum, and subcortical structures
- Allen Brain Atlas: Expression data available at Human Brain Atlas
Given its central role in protein homeostasis, HSPA1A is a therapeutic target:
- Hsp70 inducers: Geranylgeranylacetone and other compounds that upregulate Hsp70 are being investigated
- Hsp70 modulators: Small molecules that enhance Hsp70 activity
- Gene therapy: Viral vector-mediated Hsp70 delivery to the brain
- Combination therapy: Hsp70 in combination with other chaperones (Hsp40, Hsp110)
- Hsp70 molecular chaperones: Emerging roles in human disease -Trends in Biochemical Sciences, 2022
- Heat shock proteins and neurodegenerative diseases: What do we know? - Nature Reviews Neurology, 2021
- Hsp70 in Alzheimer's disease: Pathogenesis and therapeutic potential - Journal of Alzheimer's Disease, 2020
- Hsp70 and alpha-synuclein: Implications for Parkinson's disease - Movement Disorders, 2019
- Targeting Hsp70 for therapeutic intervention in ALS - Neurobiology of Disease, 2021
The study of Hspa1A Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Links verified: 2026-03-16